Among these, the expression levels of FOXK2, FOXO3, and FOXP1 were found lower in the lungs of COVID-19 patients, compared to controls (see Fig. 3C), thus showing the same expression levels and trends as observed for ATP2B1 (Fig. EV1G,H). This evidence concerns the gene FOXK2 and COVID-19.